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Dear editor, 
the association between lymphomas and auto-
immune manifestations, as well as the prevalence of 
the cases of coexistent lymphomas and autoimmune 
conditions, has not been completely established (1-
3). Since cutaneous t-cell lymphoma (CtCL) cases 
are rare, any hypothesis can only be based on case 
reports or small case series. 
We present the case of a male patient with follicu-
lotropic mycosis fungoides (FMF) and synchronous 
autoimmune hepatitis (Aih) with extremely high 
levels of cancer antigen 19-9 (CA 19-9). the patient 
was under the supervision of a multidisciplinary team 
consisting of dermatologists, hepatologists, and he-
matologists. the patient died 15 months after the 
diagnoses of FMF and Aih were established and 3.5 
years after the first skin changes. Based on our knowl-
edge and search of medical databases, this is the first 
case of Aih in a patient with CtCL, i.e. with MF.
A 53-year-old male patient was admitted to our 
Dermatology Clinic in September 2014 after being 
briefly treated with acitretin. During hospitalization, 
he was diagnosed with FMF, autoimmune hepatitis, 
and newly developed diabetes mellitus. At the time 
of hospital admission, about 70 percent of the sur-
face of the skin was affected, infiltrated with numer-
ous cysts on the face, neck, and upper thorax. the 
patient also presented with alopecia affecting most 
of the scalp, loss of eyebrows and eyelashes (Figure 
1), and complained of intensive itching. the clinical 
presentation suggested the diagnosis of FMF, which 
was later confirmed based on histological (Figure 2) 
and immunohistochemical (Figure 3) findings. the 
histochemical staining method PAS-Alcian did not 
reveal mucin deposits. immunohistochemical find-
ings revealed tumor cells to show aberrant t-immu-
nophenotypes - CD3+, CD2+, CD5-, CD7-, CD4+, CD8-, 
CD30-. Due to elevated serum conjugated bilirubin 
and extremely high levels of hepatocellular and cho-
lestatic liver enzymes, the patient was transferred to 
the Gastroenterology Department. Diagnosis of Aih 
Figure 1. Clinical findings: cystic and comedo-like lesions 
on the head and neck, partial loss of hair, eyebrows, and 
lashes, yellow sclera
Figure 2. histological features: folliculotropic infiltrate and 
intrafollicular collection of atypical lymphocytes (hematox-
ylin and eosin, original magnification ×40).
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was established based on the liver biopsy (highly ac-
tive autoimmune hepatitis) and the exclusion of viral 
etiology, drug-induced hepatotoxicity, and inherited 
metabolic disorders of the liver. CA 19-9 level was ex-
tremely high (4475.0; rr <37.0 µg/L). in March 2015, 
CA 19-9 decreased to 365.3. in April 2015, erythro-
derma and small isolated tumors on the trunk and 
extremities developed. the patient was treated with 
re-PUVA and radio-therapy. in June 2015, due to sys-
temic symptoms, the patient was started on PUVA 
with iFNα. in November 2015, erythroderma persist-
ed together with larger and ulcerated tumors. the pa-
tient was treated at the hematological Department 
with two cycles of cyclophosphamide, vincristine, 
doxorubicin, and methylprednisolone. From March 
2015, the patient was continuously treated with urso-
deoxycholic acid, prednisolone, azathioprine, analog 
insulin, and allopurinol. MSCt revealed lymphoma 
infiltrates in the liver, spleen, and peritoneum (gross 
tumors). the immunophenotypic analysis of the cells 
in ascites revealed atypical lymphocytes with convo-
luted nuclei - LCA+, CD3+, CD20-. the patient died in 
December 2015 due to sepsis with febrile neutrope-
nia. Before death, he suffered from candidiasis and 
toxic liver damage due to fluconazole. 
FMF is an aggressive MF variant with infiltration 
of lymph nodes, visceral involvement at an earlier 
stage, and decreased life expectancy (4). Autoim-
mune hepatitis (Aih) is still an unclear progressive 
liver disease of unknown etiology which features 
hypergammaglobulinemia, detectable autoantibod-
ies, and interface hepatitis (5). Being exposed to xe-
nobiotic (acitretin) with consequent liver damage 
could lead to the formation of self-antigens to which 
the patient’s immune system might have sensitized, 
and the autoimmune attack continued (6). Slightly el-
evated CA 19-9 levels in autoimmune hepatitis were 
reported by other authors (7-9). it should be noted 
that the liver involvement with atypical lymphocytes 
can be diffuse without any detectable nodules on a 
Ct scan (4). Soluble liver antigen and liver-pancreas 
antibodies, together with CA 19-9, need to be imple-
mented as routine diagnostic tools to rationalize the 
usage of tumor markers in day-to-day practice as well 
in diagnosis of Aih (10).
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